Active · per the CBE, 16 November 2026

NARCOMEDI

BE0790342241

Rechtspersoon Private limited company 1 establishment

NARCOMEDI is a specialist medical practice in Lasne. Private Limited, started on 1 September 2022, 1 establishment.

Rue des Saules 62, 1380 Lasne [email protected]

Behind the company: nooshin nasser gharaee.

Active for

4 year, 2 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

NARCOMEDI from Lasne, company number BE0790342241, closed financial year 2025 with a result of € 94,428 after tax. For that financial year NARCOMEDI recorded a gross margin of € 142,694 and equity of € 216,959. Compared with financial year 2024, the result moved from € 57,012 to € 94,428. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 216,959

▲ 77% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 94,428

▲ 66% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 132,104

▲ 67% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 213,959.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate

€ 6,292

▲ 180% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 27,584

▼ 36% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 31,512

▼ 32% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 23,250

▲ 162% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 46,675

▲ 12% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
202320242025Change 2024 → 2025
Gross margin € 102,837 € 101,432 € 142,694 ▲ 41%
Profit after taxes € 62,518 € 57,012 € 94,428 ▲ 66%
Equity € 65,518 € 122,531 € 216,959 ▲ 77%
Total debts € 81,699 € 96,693 € 101,644 ▲ 5%
Cash € 18,850 € 79,282 € 132,104 ▲ 67%
Retained profit € 62,518 € 119,531 € 213,959 ▲ 79%
Bank debt € 60,902 € 46,231 € 31,512 ▼ 32%
Balance sheet total € 147,217 € 219,224 € 318,602 ▲ 45%

By gross margin, NARCOMEDI ranks 26th of 48 companies with main activity “Activiteiten van medisch specialisten” in Lasne that publish figures (fiscal year 2025).

Key figures of NARCOMEDI, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NARCOMEDI?

What happened at NARCOMEDI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 94,428 (▲ 66% vs 2024). Source: NBB ↗
  • New establishment in Tervuren. KBO
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • nooshin nasser gharaee became a director. NBB

In short

From € 62,518 profit in 2023 to € 94,428 profit in 2025.

Paid € 57,060 in corporate taxes since 2023.

Best year ever: 2025, with € 94,428 profit.

Management

nooshin nasser gharaee
NARCOMEDI

Behind NARCOMEDI is nooshin nasser gharaee.

Directors

According to the 2025 annual accounts

nooshin nasser gharaee

Administrator-manager

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Saules 62

1380 Lasne

2.339.579.721

Oppemstraat 12 box 8

3080 Tervuren

Active since 19 September 2022

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Lasne

Same main activity (Activiteiten van medisch specialisten), 50 active companies in Lasne, largest first.

SILVANHEM

€ 604,172 gross margin · 2025

Dr BARO.J

€ 486,181 gross margin · 2025

NC MEDICA

€ 458,309 gross margin · 2025

TROUSSEL MEDICAL SOCIETY

€ 384,034 gross margin · 2025

HEA ophtalmologie

€ 375,462 gross margin · 2025

S.B.S. MEDICAL

€ 344,198 gross margin · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • NASSER GHARAEE Nooshin(oprichter) 100%

Details

Company number
0790.342.241
VAT number
BE 0790.342.241
Registered office
Rue des Saules 62, 1380 Lasne
Names & denominations
NARCOMEDI
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 September 2022
Peppol
Not registered
Activities · NACE

Activiteiten van medisch specialisten

Frequently asked questions

What does NARCOMEDI do?
NARCOMEDI is a specialist medical practice in Lasne. Private Limited, started on 1 September 2022, 1 establishment.
What is the address of NARCOMEDI?
The registered office of NARCOMEDI is located at Rue des Saules 62, 1380 Lasne.
Is NARCOMEDI still active?
Yes. According to the CBE (16 November 2026) NARCOMEDI is active, legal situation “Normale toestand”, started on 1 September 2022.
Is NARCOMEDI registered on Peppol?
No, NARCOMEDI is currently not registered on the Peppol network.
What is the enterprise number of NARCOMEDI?
The enterprise number of NARCOMEDI is BE0790342241.
When was NARCOMEDI founded?
NARCOMEDI was founded on 1 September 2022.